在心房的代谢重塑:表现,机制和临床影响
David Bode1,2, Julius Ryan D Pronto3,4, Gabriele G Schiattarella5,6,7,8
1Max Rubner Center for Cardiovascular Metabolic Renal Research (MRC), Deutsches Herzzentrum der Charité (DHZC), Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nature reviews. Cardiology
|May 30, 2024
概括
心房动 (AF) 与糖尿病和肥胖等代谢障碍有关. 准代谢变化为治疗AF和改善患者结果提供了一个有希望的策略.
科学领域:
- 心脏病学 心脏病学
- 代谢医学是一种代谢医学.
- 生物化学 生物化学
背景情况:
- 心房动 (AF) 是一个不断增长的健康负担,经常与糖尿病和肥胖等代谢障碍同时发生.
- 现有的AF治疗方法往往不足以预防不良结果.
- 代谢障碍越来越多地被认为是通过结构和电生理学心房重塑来促进AF的发展.
研究的目的:
- 在代谢障碍的背景下,审查当前对心房的理解.
- 探索AF和代谢变化之间的双向关系,包括代谢重塑.
- 讨论针对AF治疗的代谢途径的治疗策略.
主要方法:
- 关于AF和代谢障碍的当前研究的文献综述.
- 分析了将代谢障碍与心房重塑联系在一起的机制.
- 评估现有和新兴的治疗策略,重点关注代谢干预.
主要成果:
- 代谢障碍通过心房的结构和电生理变化促进AF.
- AF本身可以诱导心房代谢的显著变化 ("代谢重塑"),影响葡萄糖,脂质和代谢,以及线粒体功能.
- 需要根据个体的新陈代谢资料量身定制的治疗策略,因为AF倾向的病因取决于病因的性质.
结论:
- 了解AF和代谢障碍之间的相互作用对于开发有效疗法至关重要.
- 准代谢重塑为新型AF治疗提供了一个有希望的途径.
- 需要进一步的研究,以解决关键的挑战,并优化患者在这个群体的结果.
更多相关视频
相关概念视频
Mechanism of Cardiac Arrhythmias
911
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
911
Disturbances in Heart Rhythm
936
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
936
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Electrophysiology of Normal Cardiac Rhythm
3.3K
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
3.3K


